Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant

Go back to Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant
(NASDAQ: COCH) Delayed: 0.63 -0.03 (4.55%)
Previous Close $0.66    52 Week High
Open $0.64    52 Week Low
Day High $0.68    P/E N/A 
Day Low $0.62    EPS
Volume 57,302